◆ Chief of the Division of Hematology and Medical Oncology in the Weill Department of Medicine at Weill Cornell Medicine and NewYork Presbyterian/Weill Cornell Medical Center
◆ Former Director of the Leon V. and Marilyn L. Rosenberg Clinical Cancer Center at Beth Israel Deaconess Medical Center 
◆ Led the early clinical development of more than 50 new anticancer agents including erlotinib, temsirolimus and nab-paclitaxel
◆ A leading physician-scientist who specializes in pancreatic cancer and drug development.